Skip to content
Governance Register

← US public companies

Amello Jason

SEC-identified person · CIK 1451805 Identifier-verified

Public-company roles (from insider filings)

CompanyCapacity as filedFilings
Tscan Therapeutics, Inc. TCRX Chief Financial Officer filed 2024–2026
Candel Therapeutics, Inc. CADL Chief Financial Officer filed 2022–2023
Pharmafrontiers Corp. pftr.ob Director filed 2017–2023
Akebia Therapeutics, Inc. AKBA SVP, CFO & Treasurer filed 2014–2020
Ziopharm Oncology INC ZIOP Executive Vice President & CFO filed 2012–2013
Genzyme Corp u4yfvwk$ CorpContrllr,ChiefAccntOfficer filed 2008–2011

All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.